Cargando…

Prognostic implication of liver fibrosis scores in patients with non-ischemic dilated cardiomyopathy

AIMS: Liver fibrosis was associated with adverse outcomes in various cardiovascular diseases. The current risk stratification of non-ischemic dilated cardiomyopathy (NIDCM) still largely depends on the left ventricular ejection fraction (LVEF). At present, the relationship between liver fibrosis and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yupeng, Song, Jingjing, Wang, Wenyao, Tang, Yi-Da
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519665/ https://www.ncbi.nlm.nih.gov/pubmed/37753057 http://dx.doi.org/10.1093/ehjopen/oead082

Ejemplares similares

Different expression and prognostic value of troponin in ischemic cardiomyopathy and non-ischemic dilated cardiomyopathy
por: Gao, Wei, et al.
Publicado: (2023)

Mechanical effects of midwall fibrosis in non-ischemic dilated cardiomyopathy
por: Taylor, Robin J, et al.
Publicado: (2014)

Pathophysiological background and prognostic implication of systolic aortic root motion in non-ischemic dilated cardiomyopathy
por: Aurich, Matthias, et al.
Publicado: (2019)

Prognostic significance of midwall fibrosis in dilated cardiomyopathy
por: Gulati, Ankur, et al.
Publicado: (2012)

Shared Genetic Etiology of Primary Dilated Cardiomyopathy and Ischemic Dilated Cardiomyopathy
por: Sun, Yang, et al.
Publicado: (2021)

Prevalence and prognostic relevance of myocardial inflammation and cardiotropic viruses in non-ischemic dilated cardiomyopathy
por: Kažukauskienė, Ieva, et al.
Publicado: (2022)

Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications
por: Nuzzi, Vincenzo, et al.
Publicado: (2022)

Selvester Score May Be a Predictor of ICD Therapies in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Kuyumcu, Mevlut Serdar, et al.
Publicado: (2022)

Objective criteria for septal fibrosis in non-ischemic dilated cardiomyopathy: validation for the prediction of future cardiovascular events
por: Mikami, Yoko, et al.
Publicado: (2016)

Left ventricular long axis strain: a new prognosticator in non-ischemic dilated cardiomyopathy?
por: Riffel, Johannes H., et al.
Publicado: (2016)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications
por: Nuzzi, Vincenzo, et al.
Publicado: (2022)

Prognosis of Coronary Atherosclerotic Burden in Non-Ischemic Dilated Cardiomyopathies
por: Canu, Marjorie, et al.
Publicado: (2021)

Association between liver fibrosis and thrombotic or bleeding events in acute coronary syndrome patients
por: Liu, Yupeng, et al.
Publicado: (2022)

Prognostic implications of myocardial fibrosis and troponin levels measured by a highly sensitive assay in non-ischemic cardiomyopathy
por: Yang, Eric Y, et al.
Publicado: (2016)

Long-Term Prognostic Value of Restitution Slope in Patients with Ischemic and Dilated Cardiomyopathies
por: Dorenkamp, Marc, et al.
Publicado: (2013)

Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy
por: Cittar, Marco, et al.
Publicado: (2021)

Prognostic implications of late gadolinium enhancement at the right ventricular insertion point in patients with non-ischemic dilated cardiomyopathy: A multicenter retrospective cohort study
por: Yi, Jeong-Eun, et al.
Publicado: (2018)

Parameters of Right Ventricle as etiological distinction between ischemic and non-ischemic dilated cardiomyopathy
por: Gomes, Hélder Andrade, et al.
Publicado: (2015)

Variations of QRS Morphology in Patients with Dilated Cardiomyopathy; Clinical and Prognostic Implications
por: Akgun, Taylan, et al.
Publicado: (2014)

Prognostic Implications of Left Ventricular Global Longitudinal Strain in Dilated Cardiomyopathy
por: Park, Mi Young
Publicado: (2020)

The Ubiquitin Proteasome System in Ischemic and Dilated Cardiomyopathy
por: Spänig, Sabine, et al.
Publicado: (2019)

Energy Metabolites as Biomarkers in Ischemic and Dilated Cardiomyopathy
por: Haas, Jan, et al.
Publicado: (2021)

Left Atrial Volume Determinants in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Mancuso, Frederico José Neves, et al.
Publicado: (2015)

Statistical suggestions for long-term outcomes for non-ischemic dilated cardiomyopathy
por: Agstam, Sourabh, et al.
Publicado: (2021)

Dilated cardiomyopathies and non-compaction cardiomyopathy
por: Hänselmann, A., et al.
Publicado: (2020)

Prognostic value of right atrial strain derived from cardiovascular magnetic resonance in non-ischemic dilated cardiomyopathy
por: Li, Yangjie, et al.
Publicado: (2022)

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

Echocardiography-based machine learning algorithm for distinguishing ischemic cardiomyopathy from dilated cardiomyopathy
por: Zhou, Mei, et al.
Publicado: (2023)

Mortality risk in dilated cardiomyopathy: the accuracy of heart failure prognostic models and dilated cardiomyopathy‐tailored prognostic model
por: Dziewięcka, Ewa, et al.
Publicado: (2020)

Risk Stratification for Sudden Cardiac Death In Patients With Non-ischemic Dilated Cardiomyopathy
por: Shekha, Karthik, et al.
Publicado: (2005)

The association between ECV and microcirculation perfusion abnormalities in non-ischemic dilated cardiomyopathy
por: Ali, Aamir, et al.
Publicado: (2014)

Statistical suggestions for long-term outcomes of non-ischemic dilated cardiomyopathy patients
por: Bursa, Nurbanu
Publicado: (2021)

Myostatin/AKT/FOXO Signaling Is Altered in Human Non-Ischemic Dilated Cardiomyopathy
por: Hildebrandt, Lea, et al.
Publicado: (2022)

Impact of implantable cardioverter defibrillator on survival in patients with non‐ischemic dilated cardiomyopathy
por: Kataoka, Naoya, et al.
Publicado: (2023)

Comparison of Semi-automated Late Gadolinium Enhancement Quantification Techniques in Measuring Septal Fibrosis in Patients with Dilated Non-Ischemic Cardiomyopathy
por: Mikami, Yoko, et al.
Publicado: (2016)

Fibrosis Microstructure Modulates Reentry in Non-ischemic Dilated Cardiomyopathy: Insights From Imaged Guided 2D Computational Modeling
por: Balaban, Gabriel, et al.
Publicado: (2018)

Additive prognostic value of red cell distribution width over late gadolinium enhancement on CMR in patients with non-ischemic dilated cardiomyopathy
por: Yi, Jeong-Eun, et al.
Publicado: (2020)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Prognostic potential of liver injury in patients with dilated cardiomyopathy: a retrospective study
por: Wang, Hai-Yan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ln73s1kb55116qohos4nsn8j8d